Covered recipient · General Payments record
SCOT D HINES
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$8,055.62
- Reported across 113 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $960.40 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Neurelis, Inc. | $196.35 | 4 |
| EISAI INC. | $120.30 | 1 |
| LivaNova USA, Inc. | $113.57 | 1 |
| ABBVIE INC. | $109.82 | 5 |
| SK Life Science, Inc. | $84.99 | 1 |
| ACADIA Pharmaceuticals Inc | $83.92 | 2 |
| TG THERAPEUTICS, INC. | $66.59 | 3 |
| PFIZER INC. | $53.15 | 3 |
| NEUROPACE, INC. | $48.84 | 3 |
| JAZZ PHARMACEUTICALS INC. | $24.73 | 1 |
| Merz Pharmaceuticals, LLC | $20.42 | 1 |
| Nevro Corp. | $20.11 | 1 |
| Biogen, Inc. | $17.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.26 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103921197 | CMS |
| ABBVIE INC. | $18.20 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103921199 | CMS |
| ABBVIE INC. | $24.72 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103921201 | CMS |
| ABBVIE INC. | $19.37 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103921203 | CMS |
| ABBVIE INC. | $19.27 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103921205 | CMS |
| ACADIA Pharmaceuticals Inc | $25.72 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147975333 | CMS |
| ACADIA Pharmaceuticals Inc | $58.20 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147975337 | CMS |
| Biogen, Inc. | $17.61 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104870540 | CMS |
| Eisai Inc. | $120.30 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110780252 | CMS |
| JAZZ PHARMACEUTICALS INC. | $24.73 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150215536 | CMS |
| LivaNova USA, Inc. | $113.57 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152799595 | CMS |
| Merz Pharmaceuticals, LLC | $20.42 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137954628 | CMS |
| Neurelis, Inc. | $11.80 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145643516 | CMS |
| Neurelis, Inc. | $14.41 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145643518 | CMS |
| Neurelis, Inc. | $24.19 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145643520 | CMS |
| Neurelis, Inc. | $145.95 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145643522 | CMS |
| NEUROPACE, INC. | $14.88 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153271990 | CMS |
| NEUROPACE, INC. | $20.03 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153271998 | CMS |
| NEUROPACE, INC. | $13.93 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153272000 | CMS |
| Nevro Corp. | $20.11 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130777987 | CMS |
| PFIZER INC. | $14.81 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131514223 | CMS |
| PFIZER INC. | $23.95 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131512684 | CMS |
| PFIZER INC. | $14.39 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131199510 | CMS |
| SK Life Science, Inc. | $84.99 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154138544 | CMS |
| TG Therapeutics, Inc. | $20.82 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136891060 | CMS |
| TG Therapeutics, Inc. | $22.18 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136891094 | CMS |
| TG Therapeutics, Inc. | $23.59 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136891114 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.